Latest Removal of cannabis from Schedule I of the Controlled Substances Act Stories
NEWPORT BEACH, Calif., Jan. 10, 2012 /PRNewswire/ -- On December 21, 2011 Cannabis Science, Inc. (OTCBB:CBIS.OB) reported many critical ailments of which the Company has identified as part of its ongoing mission to capture the market share. One of which is Cancer with estimated Global drug sales growth at a compounded annual rate of 12 to 15 percent, reaching $75 to $80 billion by 2012. Conservatively speaking, if the Company is able to capture only 1% (one percent) of the Cancer...
Washington state and Rhode Island governors filed a petition with the U.S. Drug Enforcement Administration (DEA) on Wednesday that would allow doctors to legally prescribe marijuana for medical treatment. Democrat Christine Gregoire of Washington and independent Lincoln Chafee of Rhode Island asked the DEA to reclassify marijuana as a schedule 2 drug from schedule 1, which would make it legal for doctors to prescribe. "Poll after poll shows an overwhelming majority of Americans now see...
The American College of Physicians (ACP) issued a new policy statement this week endorsing medical marijuana use. The group is urging the government to reverse its ban on medical treatments using marijuana."ACP encourages the use of nonsmoked forms of THC (the main psychoactive element in marijuana) that have proven therapeutic value," the new policy statement said.The group also advocates research into other therapeutic uses of marijuana.The Philadelphia-based organization, the...
